Annual report [Section 13 and 15(d), not S-K Item 405]

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

v3.26.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Beginning balance, value at Mar. 31, 2024 $ 203,209 $ (194,349) $ (2,723) $ 6,137
Beginning balance, shares at Mar. 31, 2024 780,371        
Proceeds from the At-the-Market sale of common stock, net of offering expenses 3,079 3,079
Proceeds from the At-the-Market sale of common stock, net of offering expenses, shares 816,894        
Payments for fractional shares related to reverse-split (1) (1)
Payments for fractional shares related to reverse-split, shares (288)        
Exercise of employee stock options   82     82
Exercise of employee stock options, shares 27,750        
Employee stock-based compensation 170 170
Employee stock-based compensation related to restricted stock grants 54 54
Employee stock-based compensation related to restricted stock grants, shares 9,538        
Foreign currency translation adjustment (1,653) (1,653)
Net loss (3,457) (3,457)
Ending balance, value at Mar. 31, 2025 206,593 (197,806) (4,376) 4,411
Ending balance, shares at Mar. 31, 2025 1,634,265        
Proceeds from the At-the-Market sale of common stock, net of offering expenses 427 427
Proceeds from the At-the-Market sale of common stock, net of offering expenses, shares 149,292        
Exercise of employee stock options 44 44
Exercise of employee stock options, shares 15,500        
Employee stock-based compensation 255 255
Foreign currency translation adjustment 1,133 1,133
Net loss (3,175) (3,175)
Ending balance, value at Mar. 31, 2026 $ 207,319 $ (200,981) $ (3,243) $ 3,095
Ending balance, shares at Mar. 31, 2026 1,799,057